Premium
The Jury Is Still Out on the Benefits and Harms of Methylphenidate for Children and Adolescents With Attention‐Deficit/Hyperactivity Disorder
Author(s) -
Storebø Ole Jakob,
Faltinsen Erlend,
Zwi Morris,
Simonsen Erik,
Gluud Christian
Publication year - 2018
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.1149
Subject(s) - methylphenidate , attention deficit hyperactivity disorder , attention deficit disorder , psychiatry , psychology , attention deficit , medicine , clinical psychology
Much remains unclear about the benefits and harms of methylphenidate for children and adolescents with attention‐deficit/hyperactivity disorder ( ADHD ). Between 2012 and 2018, we conducted two Cochrane systematic reviews on methylphenidate for ADHD . This article explores the main findings in relation to evidence‐based practice and our current understanding of ADHD .[1][Storebø, O.J., 2015], [2][Storebø, O.J., 2018]